Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2021-11-15 00:00:00 ET · period of report 2021-11-15 · accession 0001367644-21-000144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-15 | 2021-11-15 | EBS | LINDAHL RICHARD S | EVP, CFO | P - Purchase | $37.46 | +3,000 | 39.9K | +8% | +$112.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-15 | P | A | 3,000 | $37.46 | 39,919 | D | — | — | (F1) The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $37.32 to $37.63. |